| Literature DB >> 22958035 |
Abstract
This review summarizes target populations of neonates for which erythropoietin (Epo) neuroprotective therapy might be of benefit, and the mechanisms by which Epo functions as a neuroprotective agent. Potential risks of Epo are reviewed. Finally, the progression of Epo neuroprotection from preclinical studies to translational studies is discussed.Entities:
Mesh:
Substances:
Year: 2012 PMID: 22958035 DOI: 10.3109/14767058.2012.715025
Source DB: PubMed Journal: J Matern Fetal Neonatal Med ISSN: 1476-4954